S. Y. Amy Cheung is Senior Director of Integrated Drug Development. Dr. Cheung has over a decade of experience working in the pharmaceutical industry at AstraZeneca (AZ), with her role as Senior Pharmacometrician and Project manager of AZ Paediatric working group. She obtained her Ph.D. from the University of Manchester, on the topic of Structural Identifiability Analysis in Pharmacokinetic and Pharmacodynamic Models. After receiving her Ph.D. she worked as a postdoc on mechanistic modeling at the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester.
She was work packages co-lead for thoughtflow and cardiac safety training for the IMI DDmoRe project and is also an active member of the EFPIA Model Informed Drug Discovery and Development (MID3) workgroup. She was a chair of IQ Consortium Clinical Pharmacology Leadership Group Pediatric Working Group in 2018 and current co-chair of IQ Consortium TALG, CPLQ PBPK Pediatric group.
- Drug development strategy
- Model-based meta analysis (MBMA)
- Physiologically-based pharmacokinetics (PBPK)
- PK/PD analysis
- Stage gate decisions/portfolio management
- Trial design
- Monoclonal antibodies